FDAnews
www.fdanews.com/articles/159510-stryker-analysts-tout-mako-buy-after-recalls-skim-q3-profits

Stryker, Analysts Tout MAKO Buy After Recalls Skim Q3 Profits

October 24, 2013
Stryker is looking forward to growth in robotics from its recent MAKO acquisition as it swallows a 70 percent earnings drop attributed to recalls and acquisitions. Costs related to the company’s Neptune 2 waste management system recall led to a decline in instrument profits, offsetting an uptick for endoscopy during the third quarter, company President and CEO Kevin Lobo said in a Thursday earnings call.
Devices & Diagnostics Letter